Peregrine Pharma (PPHM) Reports In-Line Q1 Loss
Tweet
Share
E-mailGet Alerts PPHM Hot Sheet
Price: $0.61 --0%
Financial Fact:
Total costs and expenses: 16.69M
Today's EPS Names:
TOWN, NRIM, GCBC, More
Financial Fact:
Total costs and expenses: 16.69M
Today's EPS Names:
TOWN, NRIM, GCBC, More
Join SI Premium – FREE
Peregrine Pharma (NASDAQ: PPHM) reported Q1 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $9.67 million versus the consensus estimate of $7.03 million.
For earnings history and earnings-related data on Peregrine Pharma (PPHM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Oceaneering (OII) Tops Q1 EPS by 5c, confirms prior guidance
- Alamos Gold (AGI) Misses Q1 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
